These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 24873780

  • 1. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
    Marfo K, Ajaimy M, Colovai A, Kayler L, Greenstein S, Lubetzky M, Gupta A, Kamal L, de Boccardo G, Masiakos P, Kinkhabwala M, Akalin E.
    Transplantation; 2014 Nov 27; 98(10):1082-8. PubMed ID: 24873780
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D, Lee J, Schwartz JE, Friedlander R, Aull M, Muthukumar T, Campbell S, Epstein D, Seshan SV, Kapur S, Sharma VK, Suthanthiran M, Dadhania D.
    Transplantation; 2015 Jun 27; 99(6):1156-64. PubMed ID: 25629531
    [Abstract] [Full Text] [Related]

  • 3. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Sancho Calabuig A, Gavela Martinez E, Puig Alcaraz N, Beltran Catalan S, Avila Bernabeu A, Crespo Albiach J, Montoro JA, Pallardo Mateu LM.
    Transplant Proc; 2012 Nov 27; 44(9):2529-31. PubMed ID: 23146444
    [Abstract] [Full Text] [Related]

  • 4. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 27; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 5. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar 27; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

  • 6. Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Pallardo Mateu LM, Beltran Catalan S, Puig Alcaraz N, Sancho Calabuig A, Gavela Martinez E, Avila Bernabeu A, Crespo Albiach J.
    Transplant Proc; 2011 Mar 27; 43(6):2154-6. PubMed ID: 21839219
    [Abstract] [Full Text] [Related]

  • 7. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD, Centeno A, Amador A, Fernandez-Bango C, Scowby CD, O'Rourke M, Hill-Matthie T, Patel R, Barrios F, Ruiz P, Chen L, Saghesima J, Ciancio G, Burke GW, Goldstein M, Chandar J, Contreras G, Roth D, Kupin W, Guerra G, Vianna R.
    Clin Transpl; 2014 Mar 27; ():171-8. PubMed ID: 26281142
    [Abstract] [Full Text] [Related]

  • 8. Influence of preoperative anti-HLA antibodies on short- and long-term graft survival in recipients with or without rituximab treatment.
    Ishida H, Furusawa M, Shimizu T, Nozaki T, Tanabe K.
    Transpl Int; 2014 Apr 27; 27(4):371-82. PubMed ID: 24438437
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):730-737. PubMed ID: 28339671
    [Abstract] [Full Text] [Related]

  • 10. De novo donor specific antibodies and patient outcomes in renal transplantation.
    DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.
    Clin Transpl; 2011 Apr 01; ():351-8. PubMed ID: 22755430
    [Abstract] [Full Text] [Related]

  • 11. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.
    Bachelet T, Martinez C, Del Bello A, Couzi L, Kejji S, Guidicelli G, Lepreux S, Visentin J, Congy-Jolivet N, Rostaing L, Taupin JL, Kamar N, Merville P.
    Transplantation; 2016 Jan 01; 100(1):159-66. PubMed ID: 26262501
    [Abstract] [Full Text] [Related]

  • 12. C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.
    Yell M, Muth BL, Kaufman DB, Djamali A, Ellis TM.
    Transplantation; 2015 Jun 01; 99(6):1151-5. PubMed ID: 25839705
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M, Torio A, Mas V, Redondo D, Pérez-Sáez MJ, Mir M, Faura A, Guerra R, Montes-Ares O, Checa MD, Pascual J.
    Transpl Immunol; 2013 Dec 01; 29(1-4):28-33. PubMed ID: 23907088
    [Abstract] [Full Text] [Related]

  • 14. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 15. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V, Venetz JP, Pantaleo G, Pascual M.
    Hum Immunol; 2009 Aug 20; 70(8):580-3. PubMed ID: 19375474
    [Abstract] [Full Text] [Related]

  • 16. Donor specific antibodies before and after kidney transplant: the University of Colorado Experience.
    Cooper JE, Gralla J, Adebiyi O, Wiseman AC, Chan L.
    Clin Transpl; 2013 Aug 20; ():407-12. PubMed ID: 25095536
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.
    Cooper JE, Gralla J, Chan L, Wiseman AC.
    Clin Transpl; 2011 Aug 20; ():359-64. PubMed ID: 22755431
    [Abstract] [Full Text] [Related]

  • 18. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 19. Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.
    Higgins R, Lowe D, Hathaway M, Williams C, Lam FT, Kashi H, Tan LC, Imray C, Fletcher S, Chen K, Krishnan N, Hamer R, Daga S, Edey M, Zehnder D, Briggs D.
    Transplantation; 2011 Oct 27; 92(8):900-6. PubMed ID: 21968524
    [Abstract] [Full Text] [Related]

  • 20. Successful transplantation across positive B-cell cross-match in deceased donor renal transplants.
    Goh A, Oei E, Vathsala A.
    Transplant Proc; 2012 Jan 27; 44(1):193-9. PubMed ID: 22310613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.